Package 70518-4264-0

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70518-4264-0
Digits Only 7051842640
Product NDC 70518-4264
Product ID 70518-4264_4009eb5c-5b55-fd95-e063-6294a90a17f2
Description

30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4264-0)

Marketing

Marketing Status
Marketed Since 2025-01-24
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4009eb5c-5b55-fd95-e063-6294a90a17f2", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993691"], "spl_set_id": ["81d251aa-a8e8-493e-94ed-12f6fb8902e6"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (70518-4264-0)", "package_ndc": "70518-4264-0", "marketing_start_date": "20250124"}], "brand_name": "Bupropion Hydrochloride", "product_id": "70518-4264_4009eb5c-5b55-fd95-e063-6294a90a17f2", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70518-4264", "generic_name": "Bupropion Hydrochloride", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "75 mg/1"}], "application_number": "ANDA203013", "marketing_category": "ANDA", "marketing_start_date": "20250124", "listing_expiration_date": "20261231"}